Correlation Between Verint Systems and Ember Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verint Systems and Ember Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verint Systems and Ember Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verint Systems and Ember Therapeutics, you can compare the effects of market volatilities on Verint Systems and Ember Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verint Systems with a short position of Ember Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verint Systems and Ember Therapeutics.

Diversification Opportunities for Verint Systems and Ember Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Verint and Ember is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Verint Systems and Ember Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ember Therapeutics and Verint Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verint Systems are associated (or correlated) with Ember Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ember Therapeutics has no effect on the direction of Verint Systems i.e., Verint Systems and Ember Therapeutics go up and down completely randomly.

Pair Corralation between Verint Systems and Ember Therapeutics

If you would invest  2,919  in Verint Systems on January 20, 2024 and sell it today you would lose (10.00) from holding Verint Systems or give up 0.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Verint Systems  vs.  Ember Therapeutics

 Performance 
       Timeline  
Verint Systems 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verint Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Verint Systems is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Ember Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ember Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Ember Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Verint Systems and Ember Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verint Systems and Ember Therapeutics

The main advantage of trading using opposite Verint Systems and Ember Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verint Systems position performs unexpectedly, Ember Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ember Therapeutics will offset losses from the drop in Ember Therapeutics' long position.
The idea behind Verint Systems and Ember Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities